197 related articles for article (PubMed ID: 20680097)
21. Upadacitinib inhibits corneal inflammation and neovascularization by suppressing M1 macrophage infiltration in the corneal alkali burn model.
Yu J; Shen Y; Luo J; Jin J; Li P; Feng P; Guan H
Int Immunopharmacol; 2023 Mar; 116():109680. PubMed ID: 36739832
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization.
Chen WL; Chen YM; Chu HS; Lin CT; Chow LP; Chen CT; Hu FR
PLoS One; 2014; 9(4):e94205. PubMed ID: 24714670
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of
Wang YL; Gao GP; Wang YQ; Wu Y; Peng ZY; Zhou Q
Mol Vis; 2017; 23():286-295. PubMed ID: 28479848
[TBL] [Abstract][Full Text] [Related]
24. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
Dell S; Peters S; Müther P; Kociok N; Joussen AM
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
[TBL] [Abstract][Full Text] [Related]
25. Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization.
Zhang X; Wang G; Wang Q; Jiang R
Mil Med; 2024 Jan; 189(1-2):374-378. PubMed ID: 36043264
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
[TBL] [Abstract][Full Text] [Related]
27. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
[TBL] [Abstract][Full Text] [Related]
28. Transient downregulation of microRNA-206 protects alkali burn injury in mouse cornea by regulating connexin 43.
Li X; Zhou H; Tang W; Guo Q; Zhang Y
Int J Clin Exp Pathol; 2015; 8(3):2719-27. PubMed ID: 26045777
[TBL] [Abstract][Full Text] [Related]
29. Characterization of C-X-C chemokine receptor type 5 in the cornea and role in the inflammatory response after corneal injury.
Balne PK; Gupta S; Landon KM; Sinha NR; Hofmann AC; Hauser N; Sinha PR; Huang H; Kempuraj D; Mohan RR
Exp Eye Res; 2023 Jan; 226():109312. PubMed ID: 36400287
[TBL] [Abstract][Full Text] [Related]
30. Interleukin (IL)-17A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model.
Liu G; Wu H; Lu P; Zhang X
Curr Eye Res; 2017 Mar; 42(3):368-379. PubMed ID: 27419340
[TBL] [Abstract][Full Text] [Related]
31. Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.
Shi W; Ming C; Liu J; Wang T; Gao H
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):55-67. PubMed ID: 20640436
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.
Sari ES; Yazici A; Aksit H; Yay A; Sahin G; Yildiz O; Ermis SS; Seyrek K; Yalcin B
Curr Eye Res; 2015 Jan; 40(1):48-55. PubMed ID: 24910898
[TBL] [Abstract][Full Text] [Related]
33. Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.
Dratviman-Storobinsky O; Avraham-Lubin BCR; Hasanreisoglu M; Goldenberg-Cohen N
Mol Vis; 2009 Nov; 15():2326-38. PubMed ID: 19936307
[TBL] [Abstract][Full Text] [Related]
34. Epithelial Membrane Protein-2 (EMP2) Antibody Blockade Reduces Corneal Neovascularization in an In Vivo Model.
Sun MM; Chan AM; Law SM; Duarte S; Diaz-Aguilar D; Wadehra M; Gordon LK
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):245-254. PubMed ID: 30646013
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effects of zerumbone in an alkali-burned corneal wound healing model.
Kim JW; Jeong H; Yang MS; Lim CW; Kim B
Int Immunopharmacol; 2017 Jul; 48():126-134. PubMed ID: 28501766
[TBL] [Abstract][Full Text] [Related]
36. Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization.
Liu G; Zhang W; Xiao Y; Lu P
Curr Eye Res; 2015 Sep; 40(9):891-901. PubMed ID: 25309995
[TBL] [Abstract][Full Text] [Related]
37. Suppression of alkali-induced oxidative injury in the cornea by mesenchymal stem cells growing on nanofiber scaffolds and transferred onto the damaged corneal surface.
Cejkova J; Trosan P; Cejka C; Lencova A; Zajicova A; Javorkova E; Kubinova S; Sykova E; Holan V
Exp Eye Res; 2013 Nov; 116():312-23. PubMed ID: 24145108
[TBL] [Abstract][Full Text] [Related]
38. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
39. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization.
Shen J; Yang X; Xiao WH; Hackett SF; Sato Y; Campochiaro PA
FASEB J; 2006 Apr; 20(6):723-5. PubMed ID: 16473886
[TBL] [Abstract][Full Text] [Related]
40. Protective roles of the TIR/BB-loop mimetic AS-1 in alkali-induced corneal neovascularization by inhibiting ERK phosphorylation.
Liu Y; Shu Y; Yin L; Xie T; Zou J; Zhan P; Wang Y; Wei T; Zhu L; Yang X; Wang W; Cai J; Li Y; Yao Y; Wang X
Exp Eye Res; 2021 Jun; 207():108568. PubMed ID: 33839112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
